Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
Arch Therapeutics, Inc. (ARTH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Norchi Terrence W (PRESIDENT AND CHIEF EXECUTIVE) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 72,435 shares
@ $0
Granted options to buy
@ $0
Granted 482,897 options to buy
@ $0.0497, valued at
$24k
|
|
| 07/08/2022 |
4
| Hicks Laurence (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 108,652 shares
@ $0
Granted 36,000 options to buy
@ $0
Granted 724,346 options to buy
@ $0.0497, valued at
$36k
|
|
| 06/09/2022 |
4
| Yrigoyen Dan (VICE PRESIDENT, SALES) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.0605, valued at
$9.1k
|
|
| 01/04/2022 |
4
| Fish Guy L. (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.095, valued at
$23.8k
|
|
| 10/13/2021 |
4
| Hicks Laurence (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.1028, valued at
$25.7k
|
|
| 10/01/2021 |
4
| Yrigoyen Dan (Vice President, Sales) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.1028, valued at
$20.6k
|
|
| 10/01/2021 |
4
| ABRAMS MICHAEL S (CFO) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $0.1028, valued at
$36k
|
|
| 10/01/2021 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.1028, valued at
$25.7k
|
|
| 10/01/2021 |
4
| DHILLON PUNIT (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.1028, valued at
$25.7k
|
|
| 10/01/2021 |
4
| Norchi Terrence W (President, CEO and Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.1028, valued at
$102.8k
|
|
| 08/11/2021 |
4
| Yrigoyen Dan (Vice President, Sales) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Granted 150,000 options to buy
@ $0.09, valued at
$13.5k
|
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2019 |
4
| Norchi Terrence W (President & CEO) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.2292, valued at
$229.2k
|
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2018 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 110,000 shares
@ $0
Granted 110,000 options to buy
@ $0.425, valued at
$46.8k
|
|
| 07/20/2018 |
4
| Norchi Terrence W (President & CEO) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 360,000 shares
@ $0
Granted 360,000 options to buy
@ $0.425, valued at
$153k
|
|
| 07/20/2018 |
4
| DAVIS RICHARD E (CFO & Treasurer) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 275,000 shares
@ $0
Granted 275,000 options to buy
@ $0.425, valued at
$116.9k
|
|
| 07/20/2018 |
4
| DHILLON PUNIT (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.425, valued at
$85k
|
|
| 07/20/2018 |
4
| DHILLON AVTAR S (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 220,000 shares
@ $0
Granted 220,000 options to buy
@ $0.425, valued at
$93.5k
|
|
| 07/18/2018 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Exercised 30,000 options to buy
@ $0.37, valued at
$11.1k
|
|
| 02/06/2017 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Granted 200,000 options to buy
@ $0.65, valued at
$130k
|
|
| 02/06/2017 |
4
| Norchi Terrence W (President & CEO) has filed a Form 4 on Arch Therapeutics, Inc. |
| 02/06/2017 |
4
| DHILLON AVTAR S (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 400,000 shares
@ $0
Granted 400,000 options to buy
@ $0.65, valued at
$260k
|
|
| 02/06/2017 |
4
| DAVIS RICHARD E (CFO & Treasurer) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 500,000 shares
@ $0
Granted 500,000 options to buy
@ $0.65, valued at
$325k
|
|
| 05/31/2016 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Bought 111,111 shares
@ $0
Bought 83,333 options to buy
@ $0.438, valued at
$36.5k
|
|
|
|
|